Press Releases

 Filter by Provider

ClearDox today introduced ClearOpx™, a new brand representing the evolution of its product, as it announces the availability of the ClearOpx OTRM™ Platform. The new brand name and platform reflect a unique ability to clearly automate operational functions.

Dianoush Dion Emami, CEO of Parkia, Inc. in Orange County, California, outlines why safety culture must come before every technical and commercial consideration in utility energy infrastructure.

LONDON, UK / ACCESS Newswire / May 6, 2026 / Guardian Metal Resources PLC (NYSE.A:GMTL)(LON:GMET)(OTCQB:GMTLF), a strategic exploration company focused on tungsten in Nevada, USA, is pleased to provide a Pre-Feasibility Study ("PFS") progress update on its 100%-owned Pilot Mountain tungsten project ("Pilot Mountain" or the "Project") located in Nevada, USA. The Company reports strong progress across all key PFS workstreams which are progressing as planned.

InterContinental Hotels Group PLC (the "Company")

Novatus Global Limited (“Novatus” “Novatus Global” or “the Company”), an award-winning provider of regulatory technology solutions and consulting services to global financial institutions, has been honoured with a King’s Award for Enterprise.

EvoluteIQ, the AI-native enterprise automation platform company, announced the appointment of Paul Maguire as Chief Growth Officer and Abhinaya S R as Chief Human Resources Officer. These appointments signify a deliberate shift in the company’s operational strategy from establishing platform credibility to executing at a global scale.

Signadori Bio SAS (“Signadori” or the “Company”), a preclinical-stage biopharmaceutical company developing a next generation, off-the-shelf, in vivo engineered, monocyte immunotherapy platform to treat solid tumours, today announced the successful completion of its seed extension financing round, bringing the total raised to €11.1 million. This latest investment was through participation from Taiho Ventures, and existing investors Sofinnova Partners and Invivo Partners.

Wolters Kluwer First-Quarter 2026 Trading Update

LONDON and PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, will today present two new developments at its Science Day 2026 event.

Planning for retirement can feel overwhelming, especially when income stability becomes your top priority. You want peace of mind knowing your savings will last throughout your later years.

Step-by-step guide to using Medisave for dental implants, including requirements, eligibility, and claim process explained simply

Discover effective gum disease treatment options for bleeding gums and infection, plus when to seek professional dental care for healthy gums

New tool helps small and mid-sized businesses handle data subject requests without dedicated privacy staff

The Admissions Reality Check: How Keith Berman is Replacing Reddit Rumors with Real Strategy

Knight-Swift Transportation Holdings Inc. (NYSE:KNX) (the “Company” or “Knight-Swift”), one of North America’s largest and most diversified freight transportation companies, announced today the pricing of $1.3 billion aggregate principal amount of 1.00% Convertible Senior Notes due 2031 (the “notes”) in a private placement (the “offering”) only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering size of $1.0 billion aggregate principal amount of notes. Knight-Swift has also granted the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $200.0 million aggregate principal amount of the notes. The sale of the notes to the initial purchasers is expected to close on May 8, 2026, subject to customary closing conditions.

Introduction: Catcrs has officially announced a new round of expansion, with plans to continuously bring in new members for key

Introduction:Catcrs has officially announced that, with the support of a professional advisory team, it has completed all compliance procedures and

Introduction:Catcrs has officially launched a new round of expansion, bringing in new team members for key positions in risk control,

New York, US, May 6, 2026 -- Since their initial collaboration in October 2025, the casual men's wear brand COOFANDY and renowned Joe Gibbs Racing driver Christopher Bell have seen their partnership strengthen. It was recently announced that the brand will return in 2026, embracing the idea of “Easy to Dress, Ready to Win,” and further integrating the spirit of racing with everyday attire to empower modern men to face every challenge on the track and in life with composure.

New York, USA, May 6, 2026 -- Style should move with a woman’s life—beautiful, effortless, and confident. Inspired by this belief, Zeagoo and Maye Musk introduce “Maye’s Picks”—a curated capsule collection for women who want comfort, polish, and timeless style every day.

New York, USA, May 6, 2026 -- As Mother's Day approaches, the true gift for moms is never just a single day on the calendar. EKOUAER, a lifestyle brand dedicated to comfortable loungewear, has joined forces with Numomish , a maternal emotional community platform, to launch a 12-day special campaign named "Steal Back the Night" on Instagram from May 5 to May 16. The campaign aims to draw society's attention to the long-overlooked "me-time" of mothers and offer them a night of restful sleep through daily giveaways.

Press release06 May 2026 - N° 8

Regulatory News:

WISeKey Issues CEO Letter to Shareholders

May 6, 2026Q1 2026 Group performance

Equinor (OSE: EQNR, NYSE: EQNR) will, after the annual general meeting on 12 May 2026, commence the second tranche of up to USD 375 million of the share buy-back programme for 2026, as announced in connection with the company’s first quarter results on 6 May 2026.

Key information relating to the cash dividend to be paid by Equinor (OSE: EQNR, NYSE: EQNR) for first quarter 2026.

Equinor (OSE:EQNR, NYSE:EQNR) delivered an adjusted operating income* of USD 9.77 billion and USD 2.86 billion after tax* in the first quarter of 2026. Equinor reported a net operating income of USD 8.78 billion and a net income of USD 3.10 billion. Adjusted net income* was USD 3.70 billion, leading to adjusted earnings per share* of USD 1.48.

Texas Criminal Defense Group expands felony DWI defense services in Fort Worth ahead of 2026 legislative changes. Over 30 new laws reshape DWI classifications, penalties, and enforcement procedures across Texas.

Workato, the leader in Enterprise Model Context Protocol (MCP) and orchestration, today announced Otto by Workato, a trusted AI teammate that executes work across systems, coordinates teams, and completes complex business processes with control built in. Otto is a digital teammate that moves from intent to action, working across every system your business runs on, with approvals, auditability, and governance from day one.

The trio unite in new campaign, It’s What You Bring, blending music, fashion, and football in a nod to the community behind the game

Ingram Micro Holding Corporation (the “Company”) announced today the pricing of the previously announced secondary public offering by Ingram Holdco, LLC, an affiliate of Platinum Equity, LLC (the “Selling Stockholder”), of 12,740,384 shares of the Company’s common stock (“Common Stock,” and such offering, the “Offering”), at a price to the public of $26.00 per share, pursuant to an automatic shelf registration statement filed with the Securities and Exchange Commission (the “SEC”).

HO CHI MINH CITY, VIETNAM - Media OutReach Newswire - 6 May 2026 - Global credit rating agency Moody's Ratings has announced the results of its periodic...

WAYNE, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a clinical-stage biotechnology company fully dedicated to developing IL-1β based treatments for immune-mediated inflammatory diseases, today announced the pricing of its underwritten public offering of 19,730,000 shares of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,400,000 shares of common stock. The shares of common stock are being sold at a public offering price of $17.75 per share and the pre-funded warrants are being sold at a public offering price of $17.749 per pre-funded warrant, which represents the per share public offering price of each share of common stock, less the $0.001 per share exercise price for each pre-funded warrant. In addition, Avalo has granted the underwriters a 30-day option to purchase up to an additional 3,169,500 shares of its common stock on the same terms and conditions. The gross proceeds to Avalo from the offering are expected to be approximately $375 million, before deducting underwriting discounts and commissions and offering expenses payable by Avalo and assuming no exercise of the underwriters’ option to purchase additional shares. All of the securities being sold in the offering are being offered by Avalo. The offering is expected to close on May 7, 2026, subject to the satisfaction of customary closing conditions.

Klamath River Restoration Wins Top National Engineering Award

NIQ (NYSE: NIQ), a global leader in consumer intelligence, today shared new learnings from its long-standing collaboration with Hisense, a leading global brand in home appliances and smart technologies. Using NIQ’s AI‑powered market intelligence, Hisense has accelerated international expansion, improved local market decision-making, and delivered measurable growth across more than 20 key markets and 12+ categories. The case study demonstrates how AI‑driven insights help global brands move faster, localize better, and compete more effectively in complex markets.

Utah-based cookie company announces Mother's Day cookie gift packages for delivery anywhere in the U.S.

NEW YORK and NEW ORLEANS, May 05, 2026 (GLOBE NEWSWIRE) --

Monserrate Atelier announces the launch of its first luxury watch collection, blending Portuguese history with contemporary watchmaking design.

NEW YORK and NEW ORLEANS, May 05, 2026 (GLOBE NEWSWIRE) --  Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until May 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against ImmunityBio, Inc. (NasdaqGS: IBRX) (“ImmunityBio” or the “Company”), if they purchased or otherwise acquired the Company’s securities between January 19, 2026 and March 24, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.